General President Mark McManus’ letter on WTO IP Waiver

Read the letter here Dear Secretary Raimondo, On behalf of the more than 359,000 hardworking men and women of the United Association of Union Plumbers and Pipefitters, I write to express our concern regarding the World Trade Organization’s (WTO) waiver of intellectual property protections for COVID-19 vaccines. Expanding the waiver to COVID-19 diagnostic devices and […]

STATEMENT CONCERNING the Impact of Drug Pricing Provisions in Reconciliation Legislation

On August 3, 2022, PILMA released the following statement regarding the impact of drug pricing provisions in the reconciliation package. Download the statement here. PILMA is a partnership committed to creating high-quality union construction jobs and fostering biopharmaceutical innovation and advancement. America’s biopharmaceutical industry is a vibrant sector supporting over 4 million U.S. jobs and […]

PILMA Letter on WTO/TRIPS Waiver 6.14.22

On June 14, 2022, PILMA sent the following letter to USTR Ambassador Tai on the proposed WTO/TRIPS waiver. Download the letter here. Dear Ambassador Tai, The Pharmaceutical Industry Labor-Management Association, which advances the dual goals of fostering innovation of life-saving cures and securing high-quality union construction jobs, continues to be concerned about developments with regard […]

PILMA Statement on Drug Importation Legislation

On June 8, 2022, PILMA released the following statement on drug importation legislation and PDUFA. Download the statement here. PILMA has a long history of opposing importation of foreign biopharmaceutical products into the U.S. due to the impact on U.S. construction jobs and patient safety. Congress is considering adding a prescription drug importation provision to […]

PILMA Letter to USTR on WTO TRIPS Waiver

On March 25, 2022, PILMA sent the following letter to U.S. Trade Representative Ambassador Tai on the consequences of eliminating patent protections on biopharmaceuticals. Download the letter here. March 25, 2022  Dear Ambassador Tai,  On behalf of the Pharmaceutical Industry Labor-Management Association, which advances the dual goals of fostering innovation of life-saving cures and securing […]

Statement on the Bipartisan Infrastructure Act

Today, PILMA released the following statement applauding the passage of the Bipartisan Infrastructure Act November 6, 2021 Download the full statement here. PILMA commends Congress for passing landmark legislation that will put union men and women to work updating our nation’s infrastructure. This bill will put the safest, best trained, and highest-skilled workers on the […]

USTR Letter: WTO TRIPS

View letter from PILMA Executive Director, Tim Dickson   October 22, 2021Katherine TaiUnited States Trade Representative600 17th Street, NWWashington, DC 20508   Dear Ambassador Tai, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), which advances the dual goals of fostering innovation of life-saving cures and securing high-quality union construction jobs, I write to reiterate […]

Statement on WTO TRIPS Intellectual Property Waiver

On May 6, 2021, PILMA released the following statement on the far reaching negative impacts of the U.S. signing on to the WTO TRIPS waiver. Download the statement here. May 6, 2021 The U.S. Trade Representative’s decision to support waiving intellectual property protections for the COVID-19 vaccine is a danger to worldwide health and security, […]

PILMA 2021 Statement on H.R. 3

On April 23, 2021, PILMA released the following statement in opposition to H.R. 3, the recently announced drug pricing proposal. Download the statement here. April 23, 2021 The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition of biopharmaceutical companies and skilled construction labor unions, reiterate our grave concerns with H.R. 3, the recently announced drug pricing […]